Loading clinical trials...
Loading clinical trials...
A Phase III, Multi-Center, Double-Blind, Placebo-Controlled, Randomized Study of Intravenous L-Citrulline in Sickle Cell Disease Presenting to Emergency Departments in Acute Vaso-Occlusive Crisis in Children, Adolescents and Young Adults (6 to 21 Years)
Conditions
Interventions
L-citrulline
Placebo
Locations
6
United States
Children's National Hospital
Washington D.C., District of Columbia, United States
University of Miami
Coral Gables, Florida, United States
Emory University
Atlanta, Georgia, United States
Johns Hopkins Hospital
Baltimore, Maryland, United States
Children's Hospital of Michigan
Detroit, Michigan, United States
East Carolina (University of North Carolina)
Greenville, North Carolina, United States
Start Date
July 25, 2025
Primary Completion Date
June 1, 2027
Completion Date
June 1, 2029
Last Updated
May 29, 2025
NCT06612268
NCT06820515
NCT07392216
NCT04416178
NCT05359991
NCT05431088
Lead Sponsor
Asklepion Pharmaceuticals, LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions